share_log

Connect Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%), etc.

康乃德生物 | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%)等

SEC announcement ·  2023/12/04 17:20
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息